| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1365-2362.32.S3.5.X |
| P698 | PubMed publication ID | 12028373 |
| P2093 | author name string | Bergman RN | |
| Finegood DT | |||
| Kahn SE | |||
| P921 | main subject | insulin resistance | Q1053470 |
| type 2 diabetes | Q3025883 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 35-45 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | European Journal of Clinical Investigation | Q15745208 |
| P1476 | title | The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes | |
| P478 | volume | 32 Suppl 3 |
| Q35837641 | A Unifying Organ Model of Pancreatic Insulin Secretion. |
| Q36616554 | AMP-activated protein kinase: Role in metabolism and therapeutic implications |
| Q36290223 | Adipocyte iron regulates adiponectin and insulin sensitivity |
| Q46391592 | Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications |
| Q38089174 | Advances in the development of AMPK-activating compounds |
| Q33585867 | Age-dependent decline in β-cell function assessed by an oral glucose tolerance test-based disposition index |
| Q36214909 | Antihypertensive treatment and new-onset diabetes mellitus |
| Q51490522 | Association between variants in the genes for adiponectin and its receptors with insulin resistance syndrome (IRS)-related phenotypes in Mexican Americans. |
| Q37282758 | Association of sleep apnea and type II diabetes: a population-based study |
| Q37061304 | Association of the Kir6.2 E23K variant with reduced acute insulin response in African-Americans |
| Q33772878 | Associations of age with serum insulin, proinsulin and the proinsulin-to-insulin ratio: a cross-sectional study |
| Q37141727 | Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus |
| Q51537680 | Berberine relieves insulin resistance via the cholinergic anti-inflammatory pathway in HepG2 cells. |
| Q51344862 | Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis. |
| Q44686996 | Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study |
| Q45282229 | Beta-cell dysfunction and low insulin clearance in insulin-resistant human immunodeficiency virus (HIV)-infected patients with lipodystrophy |
| Q36198965 | Beta-cell preservation: a potential role for thiazolidinediones to improve clinical care in Type 2 diabetes |
| Q53684282 | Body composition and cardiometabolic health: the need for novel concepts. |
| Q37355732 | Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects |
| Q30433331 | Candidate loci for insulin sensitivity and disposition index from a genome-wide association analysis of Hispanic participants in the Insulin Resistance Atherosclerosis (IRAS) Family Study |
| Q50056959 | Cardiometabolic Risk in PCOS: More than a Reproductive Disorder |
| Q38618607 | Cell cycle-related metabolism and mitochondrial dynamics in a replication-competent pancreatic beta-cell line. |
| Q46882093 | Characterization of insulin resistance syndrome in children and young adults. When to screen for prediabetes? |
| Q51322645 | Comparison of vildagliptin and glimepiride: effects on glycaemic control, fat tolerance and inflammatory markers in people with type 2 diabetes. |
| Q37261174 | Components of metabolic syndrome and 5-year change in insulin clearance - the Insulin Resistance Atherosclerosis Study |
| Q36016914 | Deletion of GαZ protein protects against diet-induced glucose intolerance via expansion of β-cell mass |
| Q58229736 | Determinants of evolving metabolic and cardiovascular benefit/risk profiles of rosiglitazone therapy during the natural history of diabetes: molecular mechanisms in the context of integrated pathophysiology |
| Q43220830 | Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study |
| Q38348481 | Diabetes in pregnancy outcomes: a systematic review and proposed codification of definitions |
| Q36934248 | Diabetic Phenotypes and Late-Life Dementia Risk: A Mechanism-specific Mendelian Randomization Study |
| Q37449087 | Dietary Protein Intake and Type 2 Diabetes Among Women and Men in Northeast China |
| Q40433596 | Discriminatory ability of simple OGTT-based beta cell function indices for prediction of prediabetes and type 2 diabetes: the CODAM study |
| Q51326908 | Disproportionately elevated proinsulinemia is observed at modestly elevated glucose levels within the normoglycemic range. |
| Q36305369 | Early impaired β-cell function in chinese women with polycystic ovary syndrome |
| Q99408763 | Effect of hydroalcoholic extract of Berberis integerrima and resveratrol on ovarian morphology and biochemical parameters in Letrozole-induced polycystic ovary syndrome rat model: An experimental study |
| Q42496887 | Effect of initial combination therapy with sitagliptin and metformin on β-cell function in patients with type 2 diabetes |
| Q51381776 | Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and pioglitazone on glycemic control and measures of β-cell function in patients with type 2 diabetes. |
| Q44185867 | Effect of maternal feed restriction during pregnancy on glucose tolerance in the adult guinea pig. |
| Q42436026 | Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach |
| Q51489068 | Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus. |
| Q51478110 | Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial. |
| Q50000790 | Empagliflozin Treatment is Associated with Improved Beta Cell Function in T2DM. |
| Q38638523 | Empagliflozin and linagliptin combination therapy for treatment of patients with type 2 diabetes mellitus |
| Q41889510 | Enhanced modelling of the glucose–insulin system and its applications in insulin therapies |
| Q34031674 | Establishment and characterization of a transgenic mouse model for in vivo imaging of Bmp4 expression in the pancreas |
| Q35793545 | Estimating tissue iron burden: current status and future prospects |
| Q43225411 | Evaluation of proposed oral disposition index measures in relation to the actual disposition index |
| Q37262330 | Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome |
| Q55053467 | Failure of islet β‐cell compensation for insulin resistance causes type 2 diabetes: What causes non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis? |
| Q46957631 | Glucose-stimulated prehepatic insulin secretion is associated with circulating alanine, triglyceride, glucagon, lactate and TNF-alpha in patients with HIV-lipodystrophy |
| Q35223401 | Higher maternal gestational glucose concentration is associated with lower offspring insulin sensitivity and altered beta-cell function |
| Q44251909 | Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test |
| Q51512241 | Hyperproinsulinaemia and risk of Type 2 diabetes mellitus in women. |
| Q46736682 | Hyperthyroidism impairs pancreatic beta cell adaptations to late pregnancy and maternal liporegulation in the rat. |
| Q92894608 | Impact of a High Intake of Dairy Product on Insulin Sensitivity in Hyperinsulinemic Adults: A Crossover Randomized Controlled Trial |
| Q33902884 | Impact of glucose dosing regimens on modeling of glucose tolerance and β-cell function by intravenous glucose tolerance test in diet-induced obese mice |
| Q46068667 | Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men. |
| Q36903389 | Impaired beta cell function is present in nondiabetic rheumatoid arthritis patients |
| Q36996564 | Impaired glucose tolerance and risk factors for progression to type 2 diabetes in youth |
| Q43227266 | Increased rate of whole body lipolysis before and after 9 days of bed rest in healthy young men born with low birth weight. |
| Q39334553 | Insulin Resistance and Mitochondrial Dysfunction. |
| Q35869619 | Insulin resistance and excess risk of diabetes in Mexican-Americans: the San Antonio Heart Study |
| Q33569169 | Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications |
| Q37712269 | Insulin resistance, beta cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Family study |
| Q37838172 | Insulin resistance: pathophysiology and rationale for treatment |
| Q36080960 | Insulin secretion based on the late oral glucose tolerance test period and incident diabetes: the San Antonio Heart Study |
| Q46678826 | Interactive influences of peroxisome proliferator-activated receptor alpha activation and glucocorticoids on pancreatic beta cell compensation in insulin resistance induced by dietary saturated fat in the rat. |
| Q36005145 | Islet adaptation to insulin resistance: mechanisms and implications for intervention |
| Q42500046 | Lentivirus shRNA Grb10 targeting the pancreas induces apoptosis and improved glucose tolerance due to decreased plasma glucagon levels |
| Q46800403 | Longitudinal changes in insulin sensitivity and secretion from birth to age three years in small- and appropriate-for-gestational-age children |
| Q36716306 | Maternal supplementation of diabetic mice with thymoquinone protects their offspring from abnormal obesity and diabetes by modulating their lipid profile and free radical production and restoring lymphocyte proliferation via PI3K/AKT signaling. |
| Q30414988 | Mechanistic systems modeling to guide drug discovery and development |
| Q64996548 | MicroRNA-18 promotes apoptosis of islet β-cells via targeting NAV1. |
| Q34655565 | Molecular insights into insulin action and secretion |
| Q36008854 | New approach to beta cell function screening by nitric oxide assessment of obese individuals at the population level |
| Q51256824 | Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: results from the TULIP study. |
| Q41613032 | OGTT 1h serum C-peptide to plasma glucose concentration ratio is more related to beta cell function and diabetes mellitus |
| Q37373479 | Obesity and T2DM in youth |
| Q42326757 | Oral salmon calcitonin attenuates hyperglycaemia and preserves pancreatic beta-cell area and function in Zucker diabetic fatty rats. |
| Q51364719 | Pancreatic iron and glucose dysregulation in thalassemia major. |
| Q37577162 | Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes |
| Q30370657 | Persistent apparent pancreatic β-cell defects in premenarchal PCOS relatives. |
| Q33993320 | Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective |
| Q34139048 | Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatment |
| Q89767901 | Pre-analytical Errors in Glucose Estimation Results in Query on Diabetic Management |
| Q35677658 | Prenatal dexamethasone exposure induces changes in nonhuman primate offspring cardiometabolic and hypothalamic-pituitary-adrenal axis function |
| Q42440083 | Presence of impaired insulin secretion and insulin resistance in normoglycemic male subjects with family history of type 2 diabetes |
| Q33666062 | Proinsulin and age in general population |
| Q46114555 | Proinsulin-to-C-peptide ratio versus proinsulin-to-insulin ratio in the prediction of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS). |
| Q45161628 | Reduced PDX-1 expression impairs islet response to insulin resistance and worsens glucose homeostasis |
| Q35895869 | Role of adipokines and other inflammatory mediators in gestational diabetes mellitus and previous gestational diabetes mellitus |
| Q37761303 | Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity |
| Q36044246 | Simultaneous measurement of insulin sensitivity, insulin secretion, and the disposition index in conscious unhandled mice |
| Q60923458 | Single-cell gene expression analysis reveals β-cell dysfunction and deficit mechanisms in type 2 diabetes |
| Q42440190 | Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function |
| Q37870930 | Sitagliptin or exenatide once weekly for type 2 diabetes: comparison of the clinical trials |
| Q34537345 | Systemically modeling the dynamics of plasma insulin in subcutaneous injection of insulin analogues for type 1 diabetes. |
| Q35544013 | The Insulin Resistance but Not the Insulin Secretion Parameters Have Changed in the Korean Population during the Last Decade. |
| Q33750703 | The T-allele of TCF7L2 rs7903146 associates with a reduced compensation of insulin secretion for insulin resistance induced by 9 days of bed rest |
| Q33969575 | The changes in early phase insulin secretion in newly diagnosed, drug naive korean prediabetes subjects |
| Q35614282 | The changing faces of diabetes |
| Q51376983 | The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus. |
| Q37984756 | The effect of linagliptin on glycaemic control and tolerability in patients with type 2 diabetes mellitus: a systematic review and meta-analysis |
| Q33705046 | The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance |
| Q37423410 | The relative associations of β-cell function and insulin sensitivity with glycemic status and incident glycemic progression in migrant Asian Indians in the United States: the MASALA study |
| Q39869525 | The shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetes |
| Q51485541 | Thiazolidinediones improve beta-cell function in type 2 diabetic patients. |
| Q27694430 | Type 2 diabetes can be prevented with early pharmacological intervention |
Search more.